UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB




(Mark  One)

[X]   QUARTERLY  REPORT  UNDER  SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
      ACT  OF  1934
                For the quarterly period ended September 30, 2004

[ ]   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
      ACT  OF  1934
                    For  the  transition  period          to



                         Commission file number 33-00215

                       UNITED STATES ANTIMONY CORPORATION

                 (Name of small business issuer in its charter)


               MONTANA                                   81-0305822
               -------                                   ----------
(State or other jurisdiction                          (I.R.S. Employer
of incorporation or organization)                     Identification No.)

          P.O.  BOX  643,  THOMPSON  FALLS,  MONTANA        59873
          ------------------------------------------       -------
        (Address  of  principal  executive  offices)     (Zip  code)


       Registrant's telephone number, including area code:  (406) 827-3523



Check  whether  the issuer (1) filed all reports required to be filed by Section
13  or  15(d) of the Exchange Act during the past 12 months (or for such shorter
period  that the registrant was required to file such reports), and (2) has been
subject  to  such  filing  requirements  for  the  past  90  days.
YES     X          No
     -----        ----


At  November  10,  2004, the registrant had outstanding 30,948,816 shares of par
value  $0.01  common  stock.


<PAGE>





                       UNITED STATES ANTIMONY CORPORATION
                         QUARTERLY REPORT ON FORM 10-QSB
                            FOR THE QUARTERLY PERIOD
                            ENDED SEPTEMBER 30, 2004


<TABLE>
<CAPTION>


                               TABLE  OF  CONTENTS


                                                                         Page

<S>                                                                      <C>
PART I - FINANCIAL INFORMATION

Item 1: Financial Statements. . . . . . . . . . . . . . . . . . . . . .   1

Item 2: Management's Discussion and Analysis of Financial Condition and
        Results of Operations     . . . . . . . . . . . . . . . . . . .   6

Item 3: Controls and Procedures . . . . . . . . . . . . . . . . . . . .   8

PART II - OTHER INFORMATION

Item 1: Legal Proceedings . . . . . . . . . . . . . . . . . . . . . . .   9

Item 2: Changes in Securities . . . . . . . . . . . . . . . . . . . . .   9

Item 3: Defaults upon Senior Securities . . . . . . . . . . . . . . . .   9

Item 4: Submission of Matters to a Vote of Security Holders . . . . . .   9

Item 5: Other Information . . . . . . . . . . . . . . . . . . . . . . .   9

Item 6: Exhibits and Reports on Form 8-K. . . . . . . . . . . . . . . .   9


SIGNATURE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  10

CERTIFICATIONS. . . . . . . . . . . . . . . . . . . . . . . . . . . . .  11



</TABLE>




         [The balance of this page has been intentionally left blank.]








<PAGE>


PART  I-FINANCIAL  INFORMATION
<TABLE>
<CAPTION>


ITEM  1.  FINANCIAL  STATEMENTS
UNITED  STATES  ANTIMONY  CORPORATION  AND  SUBSIDIARY
CONSOLIDATED  BALANCE  SHEETS
                                                                      (UNAUDITED)
                                                                     SEPTEMBER  30,     DECEMBER  31,
                                                                          2004            2003
                                                         ASSETS

<S>                                                                       <C>             <C>
Current assets:
Accounts receivable, less allowance
    for doubtful accounts of $30,000                                $     131,814   $     51,081
  Inventories                                                             132,658        153,053
                                                                    --------------  -------------
          Total current assets                                            264,472        204,134

Investment in USAMSA, net                                                   9,463         11,913
Properties, plants and equipment, net                                     645,678        554,311
Restricted cash for bank note payable                                           0        105,649
Restricted cash for reclamation bonds                                      99,043         99,043
Deferred financing costs                                                   24,375         30,000
                                                                    --------------  -------------
          Total assets                                              $   1,043,031   $  1,005,050
                                                                    ==============  =============

LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
  Checks issued and payable                                         $     107,687   $     87,927
  Accounts payable                                                        638,550        909,696
  Accrued payroll and property taxes                                      148,069        197,761
  Accrued payroll and other                                                83,560         88,085
  Judgment payable                                                         55,680         53,130
  Accrued interest payable                                                 21,619         16,645
  Payable to related parties                                              286,867        232,111
  Notes payable to bank, current                                          191,494        144,391
  Accrued reclamation costs, current                                      151,000        151,000
                                                                    --------------  -------------
          Total current liabilities                                     1,684,526      1,880,746

Secured and unsecured convertible notes payable, non-current              350,000        350,000
Notes payable to bank, noncurrent                                         382,778        409,141
Accrued reclamations costs, noncurrent                                     57,500         57,500
                                                                    --------------  -------------
          Total liabilities                                             2,474,804      2,697,387
                                                                    --------------  -------------

Commitments and contingencies (Note 3)
Stockholders' deficit:
  Preferred stock, $0.01 par value, 10,000,000 shares authorized:
      Series A: 4,500 shares issued and outstanding
        (liquidation preference $123,750 at December 31, 2003)                 45             45
      Series B: 750,000 shares issued and outstanding
        (liquidation preference $825,000 at December 31, 2003)              7,500          7,500
      Series C: 177,904 shares issued and outstanding
        (liquidation preference $97,847 at December 31, 2003)               1,779          1,779
      Series D: 1,836,672 shares issued and outstanding
        (liquidation preference $4,659,180 at December 31, 2003)           18,636         18,636
  Common stock, $0.01 par value, 50,000,000 shares
    authorized; 30,948,816 and 28,114,288 issued and outstanding          309,489        281,143
  Additional paid-in capital                                           17,946,984     17,387,970
  Accumulated deficit                                                 (19,716,206)   (19,389,410)
                                                                    --------------  -------------
          Total stockholders' deficit                                  (1,431,773)    (1,692,337)
                                                                    --------------  -------------
          Total liabilities and stockholders' deficit                   1,043,031   $  1,005,050
                                                                    ==============  =============
</TABLE>


The accompanying notes are an integral part of the financial statements.
                                        1


<PAGE>


UNITED  STATES  ANTIMONY  CORPORATION  AND  SUBSIDIARY
CONSOLIDATED  STATEMENTS  OF  OPERATIONS  (UNAUDITED)

<TABLE>
<CAPTION>


                                                       FOR THE THREE MONTHS ENDED     FOR THE NINE MONTHS ENDED
                                                       SEPTEMBER 30,  SEPTEMBER 30,  SEPTEMBER 30,  SEPTEMBER 30,
                                                           2004           2003           2004          2003

<S>                                                         <C>           <C>           <C>           <C>
Revenues:
  Sales of antimony products                          $   569,361   $   678,060   $ 1,662,100   $ 2,239,915
  Sales of zeolite products                               249,585        85,291       786,683       349,049
                                                      ------------  ------------  ------------  ------------
                                                          818,946       763,351     2,448,783      2,588,964
                                                      ------------  ------------  ------------  ------------

Cost of sales:
  Cost of antimony production                             432,357       511,991     1,281,592     1,757,911
  Antimony freight and delivery                            38,671        67,042       118,354       207,355
  Antimony depreciation                                     8,425         9,475        29,025        28,428
                                                      ------------  ------------  ------------  ------------
     Total antimony cost of sales                         479,453       588,508     1,428,971     1,993,694


  Cost of zeolite production                              130,795        98,303       477,715       350,840
  Zeolite freight and delivery                             65,434        22,318       195,948        60,969
  Zeolite depreciation                                     22,031        13,686        49,631        41,058
                                                        ------------  ------------  ------------  -----------
     Total zeolite cost of sales                          218,260       134,307       723,694       452,867
                                                        ------------  ------------  ------------  -----------

     Total cost of sales                                 697,713       722,815     2,152,265      2,446,561
                                                      ------------  ------------  ------------  ------------

Gross profit                                              121,233        40,536       296,518       142,403
                                                      ------------  ------------  ------------  ------------

Other operating expenses:
  Corporate general and administrative                     93,937        91,824       246,108       316,558
  Antimony general and administrative                       5,872         9,448         6,245        14,593
  Bear River Zeolite general and administrative            56,936        47,872       146,886       191,046
  Antimony sales expenses                                  11,249        17,028        37,123        51,994
  Bear River Zeolite sales expenses                        13,243        20,652        47,834        49,917
                                                      ------------  ------------  ------------  ------------
                                                          181,237       186,824       484,196        624,108
                                                      ------------  ------------  ------------  ------------
Other (income) expense:
  Interest expense                                         18,823        21,266        76,608        54,293
  Factoring expense                                        25,113        22,320        65,356        83,544
  Interest income and other                                  (383)         (544)       (2,846)       (6,193)
                                                      ------------  ------------  ------------  ------------
                                                           43,553        43,042       139,118        131,644
                                                      ------------  ------------  ------------  ------------

Net loss                                              $  (103,557)  $  (189,330)  $  (326,796)  $  (613,349)
                                                      ============  ============  ============  ============

Basic net loss per share of common stock              $    Nil      $     (0.01)  $     (0.01)  $     (0.02)
                                                      ============  ============  ============  ============

Basic weighted average shares outstanding              30,929,251    27,027,959    29,958,360    26,865,026
                                                      ============  ============  ============  ============
</TABLE>



 The accompanying notes are an integral part of the financial statements.
                                        2



<PAGE>


UNITED  STATES  ANTIMONY  CORPORATION  AND  SUBSIDIARY
CONSOLIDATED  STATEMENTS  OF  CASH  FLOWS  (UNAUDITED)
<TABLE>
<CAPTION>


                                                                  FOR  THE  NINE  MONTHS  ENDED
                                                                  SEPTEMBER  30,  SEPTEMBER  30,
                                                                      2004          2003

<S>                                                                  <C>         <C>
Cash flows from operating activities:
  Net loss                                                           $(326,796)  $(613,349)
  Adjustments to reconcile net loss to net cash used by operations:
    Depreciation and amortization                                       86,731      75,986
    Series D stock issued to directors                                       0      15,000
    Series D stock issued for legal services                                 0       7,800
  Change in:
      Restricted cash                                                  105,649      20,100
      Accounts receivable                                              (80,733)    (11,484)
      Inventories                                                       20,395      51,146
      Accounts payable                                                (121,001)     55,118
      Accrued payroll and property taxes                               (49,692)    124,933
      Accrued payroll and other                                         (4,525)    (39,444)
      Judgment payable                                                   2,550       1,017
      Accrued interest payable                                           4,974       2,550
      Payable to related parties                                        54,756      (4,023)
      Accrued reclamation costs                                              0     (25,082)
                                                                     ----------  ----------
        Net cash used by operating activities                         (307,692)   (339,732)
                                                                     ----------  ----------

Cash flows from investing activities:
  Purchase of properties, plants and equipment                        (170,023)   (101,326)
                                                                     ----------  ----------
        Net cash used by investing activities                         (170,023)   (101,326)
                                                                     ----------  ----------

Cash flows from financing activities:
  Proceeds from stock subscriptions payable                                  0     275,000
  Proceeds from issuance of common stock and warrants                   10,000           0
  Proceeds from exercise of warrants                                   427,215           0
  Proceeds from notes payable to bank                                  174,419     150,000
  Principal payments on notes payable to bank                         (153,679)   (117,770)
  Proceeds from related party advances, net                                  0      75,027
  Change in checks issued and payable                                   19,760      58,801
                                                                     ----------  ----------
        Net cash provided by financing activities                      477,715     441,058
                                                                     ----------  ----------

Net change in cash                                                           0           0
Cash, beginning of period                                                    0           0
                                                                     ----------  ----------
Cash, end of period                                                  $       0   $       0
                                                                     ==========  ==========

Supplemental disclosures:
  Non-cash financing activities:
    Common stock issued in satisfaction of accounts payable          $ 150,145
                                                                     ==========

</TABLE>



 The accompanying notes are an integral part of the financial statements.
                                        3

<PAGE>

PART  I  -  FINANCIAL  INFORMATION,  CONTINUED:

UNITED  STATES  ANTIMONY  CORPORATION  AND  SUBSIDIARY
NOTES  TO  CONSOLIDATED  FINANCIAL  STATEMENTS  (UNAUDITED)

1. BASIS  OF  PRESENTATION:

The  unaudited  consolidated  financial  statements  have  been  prepared by the
Company  in  accordance  with  accounting  principles  generally accepted in the
United  States  of  America  for  interim  financial information, as well as the
instructions  to  Form  10-QSB.  Accordingly,  they  do  not  include all of the
information  and  footnotes required by accounting principles generally accepted
in  the  United  States  of  America  for  complete financial statements. In the
opinion  of  the  Company's management, all adjustments (consisting primarily of
normal  recurring  accruals) considered necessary for a fair presentation of the
interim financial statements have been included. Operating results for the three
and  nine  month periods ended September 30, 2004 are not necessarily indicative
of  the results that may be expected for the full year ending December 31, 2004.
Certain  consolidated  financial  statement amounts for the three and nine-month
periods  ended       September 30, 2003 have been reclassified to conform to the
2004  presentation.  These  reclassifications  had  no effect on the net loss or
accumulated  deficit  as  previously  reported.

For  further information refer to the financial statements and footnotes thereto
in  the  Company's  Annual Report on Form 10-KSB for the year ended December 31,
2003.

2. LOSS  PER  COMMON  SHARE:

The  Company  accounts  for  its income (loss) per common share according to the
Statement  of Financial Accounting Standards No. 128 "Earnings Per Share" ("SFAS
No.  128").  Under  the  provisions  of  SFAS No. 128, primary and fully diluted
earnings  per  share  are  replaced  with  basic and diluted earnings per share.
Basic  earnings  per share is arrived at by dividing net income (loss) available
to  common  stockholders  by  the  weighted  average  number  of  common  shares
outstanding,  and does not include the impact of any potentially dilutive common
stock equivalents.  Common stock equivalents, including warrants to purchase the
Company's  common  stock  and  common  stock  issuable  upon  the  conversion of
debentures are excluded from the calculations when their effect is antidilutive.

3. COMMITMENTS  AND  CONTINGENCIES:

Until  1989, the Company mined, milled and leached gold and silver in the Yankee
Fork  Mining District in Custer County, Idaho. In 1994, the U.S. Forest Service,
under  the  provisions of the Comprehensive Environmental Response Liability Act
of  1980  ("CERCLA"), designated the cyanide leach plant as a contaminated site.
In  1996,  the  Idaho  Department  of  Environmental  Quality requested that the
Company  sign  a  consent  decree  related  to  completing  the  reclamation and
remediation  at  the  Preachers  Cove  mill.  The  Company  has  been diligently
reclaiming the property and anticipates it will have the reclamation complete in
the  near  term.

The  Company's  management  believes  that  USAC  is  currently  in  substantial
compliance  with  environmental  regulatory  requirements  and  that its accrued
environmental  reclamation  costs are representative of management's estimate of
costs  required  to fulfill its reclamation obligations.  Such costs are accrued
at  the  time  the  expenditure becomes probable and the costs can reasonably be
estimated.  The  Company  recognizes,  however,  that  in  some  cases  future
environmental  expenditures cannot be reliably determined due to the uncertainty
of  specific remediation methods, conflicts between regulating agencies relating
to  remediation  methods  and  environmental law interpretations, and changes in
environmental  laws  and  regulations.

                                  4
<PAGE>

UNITED  STATES  ANTIMONY  CORPORATION  AND  SUBSIDIARY
NOTES  TO  CONSOLIDATED  FINANCIAL  STATEMENTS  (UNAUDITED),  CONTINUED:

3. COMMITMENTS  AND  CONTINGENCIES,  CONTINUED:

Any  changes  to  the  Company's  reclamation plans as a result of these factors
could have an adverse affect on the Company's operations.  The range of possible
losses  in  excess of the amounts accrued cannot be reasonably estimated at this
time.

4.     BUSINESS  SEGMENTS

The  Company  has  two  operating  segments,  antimony  and zeolite.  Management
reviews and evaluates the operating segments exclusive of interest and factoring
expenses.  Therefore,  interest  expense  is  not  allocated  to  the  segments.
Selected  information  with  respect  to  segments  for  the  quarters  ended
September  30,  2004  and  2003  are  as  follows:
<TABLE>
<CAPTION>


                                                      2004     2003

<S>                                                <C>       <C>
Revenues:
    Antimony                                       $569,361  $678,060
    Zeolite                                         249,585    85,291
                                                   --------  --------
                                                   $818,946  $763,351
                                                   ========  ========
Cost of sales:
    Antimony production and freight and delivery   $471,028  $579,033
    Antimony depreciation                             8,425     9,475
                                                   --------  --------
      Total antimony cost of sales                  479,453   588,508

    Zeolite production and freight and delivery     196,229   120,621
    Zeolite depreciation                             22,031    13,686
                                                   --------  --------
                                                    218,260   134,307

                                                   $697,713  $722,815
                                                   ========  ========

Gross profit (loss)                                $121,233  $ 40,536
                                                   ========  ========

Other operating expenses:
  Sales expense:
    Antimony                                       $ 11,249  $ 17,028
    Zeolite                                          13,243    20,652
  General and administrative expense:
    Corporate                                        93,937    91,824
    Antimony                                          5,872     9,448
    Zeolite (including royalty expense)              56,936    47,872
                                                   --------  --------
                                                   $181,237  $186,824
                                                   ========  ========

Capital expenditures:
    Antimony                                       $      0  $ 23,491
    Zeolite                                          42,735    45,263
                                                   --------  --------
                                                   $ 42,735  $ 68,754
                                                   ========  ========

Properties, plant and equipment, net:
    Antimony                                       $119,783  $142,950
    Zeolite                                         525,895   418,306
                                                   --------  --------
                                                   $645,678  $561,256
                                                   ========  ========
</TABLE>




                        5
<PAGE>


ITEM  2.  MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OF FINANCIAL CONDITION AND
          RESULTS  OF OPERATIONS

General

This  report  contains both historical and prospective statements concerning the
Company  and  its operations.  Prospective statements (known as "forward-looking
statements")  may  or  may  not  prove  true with the passage of time because of
future  risks  and uncertainties.  The Company cannot predict what factors might
cause  actual  results  to differ materially from those indicated by prospective
statements.

Results  of  Operations

For  the three-month period ended September 30, 2004 compared to the three-month
period  ended  September  30,  2003

The  Company's operations resulted in a net loss of $103,557 for the three-month
period  ended     September  30,  2004, compared with a net loss of $189,330 for
the three-month period ended September 30, 2003. The decrease in net loss during
the  second  quarter of 2004 compared to the net loss during the similar quarter
of  2003  is  primarily  due  to  an  increase  in  zeolite  sales.

Total  revenues  from antimony product sales for the second quarter of 2004 were
$569,361  compared  with  $678,060  during  the  comparable  quarter  of 2003, a
decrease  of  $108,699.  During the three-month period ended September 30, 2004,
70% of the Company's revenues from antimony product sales were from sales to one
customer (Kohler, Co.).  Sales of antimony products during the third quarter of
2004 consisted of 392,872 pounds at an average sale price of $1.45 per pound.
During the third quarter  of  2003  sales  of antimony products consisted of
529,457 pounds at an average  sale  price of $1.28 per pound. The increase in
sale prices of antimony products  from  the  third  quarter  of 2003 to the
third quarter of 2004 is the result  of  a  corresponding increase in antimony
metal prices.  The decrease in pounds  of  antimony  sold is attributed to
difficulties in procuring low priced raw  material  inventory  and  competition
from  Chinese  suppliers.

Sales  of  zeolite  products  during  the  third  quarter  of 2004 were $249,585
compared  to sales of $85,291 during the third quarter of 2003.  The increase in
sales of zeolite is due to the Company expanding its zeolite plant and expanding
its  product  base.

Gross profit from antimony and zeolite sales during the third three-month period
of  2004  was  $121,233  compared  with gross profit of $40,536 during the third
three-month  period  of  2003.

During the third quarter of 2004, the Company incurred expenses totaling $70,179
associated with sales development and general and administrative expenses of its
wholly-owned  subsidiary, Bear River Zeolite, compared to $68,524 of expenses in
the  comparable  quarter  of 2003.  The increase in BRZ expenses was principally
due  to  an increase in general and administrative expenses in the third quarter
of  2004.

Antimony  general  and  administrative  expenses  were  $99,809 during the third
quarter  of  2004,  compared  to  $101,272  during  the  same  quarter  of 2003.

Antimony  sales  expenses were $11,249 during the third quarter of 2004 compared
with  $17,028  in  the  third  quarter  of  2003.

Interest  expense  was  $18,823  during  the  third quarter of 2004, compared to
interest  expense  of  $21,266  incurred  during  the third quarter of 2003; the
decrease  in  interest  expense  was  due  to  the additional convertible notes.

Accounts  receivable  factoring  expense was $25,113 during the third quarter of
2004  compared to $22,320 of factoring expense incurred during the third quarter
of  2003.

                                6
<PAGE>

ITEM  2.  MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OF FINANCIAL CONDITION AND
          RESULTS  OF OPERATIONS,  CONTINUED:

Interest  and  other  income  decreased to $383 during the third quarter of 2004
from  $544  during  the  third  quarter  of  2003.

For  the  nine-month  period ended September 30, 2004 compared to the nine-month
period  ended  September  30,  2003

The  Company's  operations resulted in a net loss of $326,796 for the nine-month
period  ended      September  30, 2004, compared with a net loss of $613,349 for
the nine-month period ended September 30, 2003. The decrease in net loss for the
first nine months of 2004 compared to the first nine months of 2003 is primarily
due  an  increase  in  gross profit and a decrease in general administrative and
sales  expense  in  2004.

Total  revenues  from  antimony  product sales for the first nine months of 2004
were  $1,662,100  compared  with $2,239,915 for the comparable period of 2003, a
decrease  of  $577,815.  During  the nine-month period ended September 30, 2004,
67%  of  the  Company's revenues from antimony products sales were from sales to
one  customer (Kohler, Co.) and 5% were from sales to a second individual
customer.  Sales of antimony  products  during  the first nine months of 2004
consisted of 1,120,833 pounds  at  an  average  sale  price  of $1.48 per pound.
During the first nine months  of  2003  sales of antimony products consisted of
1,716,534 pounds at an average  sale  price of $1.30 per pound. The decrease in
pounds of antimony sold is attributed to difficulties in procuring low priced
raw material inventory and competition  from  Chinese  suppliers.  The  increase
in sale prices of antimony products  from the first nine months of 2004 to the
first nine months of 2003 is the  result  of  a  corresponding  increase  in
antimony  metal  prices.

Sales  of  zeolite  products  during the first nine months of 2004 were $786,683
compared  to  sales  of  $349,049  during  the  comparable  period of 2003.  The
increase  in  sales of zeolite is due to the Company expanding its zeolite plant
and  expanding  its  product  base.

Gross  profit from antimony and zeolite sales during the first nine-month period
of  2004  was  $296,518  compared  with gross profit of $142,403 during the same
nine-month  period  of  2003.

During  the  first  nine  months of 2004, the Company incurred expenses totaling
$194,720  associated  with  sales  development  and  general  and administrative
expenses  of  its  wholly  owned  subsidiary,  Bear  River  Zeolite, compared to
$240,963  of expenses during the comparable period of 2003.  The decrease in BRZ
expenses  was  principally  due  to  a  decrease  in  general and administrative
expenses.

Antimony general and administrative expenses were $252,353 during the first nine
months  of 2004, compared to $331,151 during the first nine months of 2003.  The
decrease  in general and administrative expenses during the first nine months of
2004  compared  to  the  same  period  of  2003  was  due to a decreased repair,
maintenance  and  legal  expenses.

Antimony  sales  expenses  were  $37,123  during  the  first nine months of 2004
compared  with  $51,994  in  the  first  nine  months  of  2003.

Interest  expense  was $76,608 during the first nine months of 2004, compared to
interest  expense  of $54,293 incurred during the first nine months of 2003. The
increase  was  due  to  increased  convertible  debt  in  2004 compared to 2003.

Accounts  receivable  factoring expense was $65,356 during the first nine months
of  2004 compared to $83,544 of factoring expense incurred during the first nine
months  of  2003.  The  decrease  was  primarily  due  to a decrease in sales of
antimony  factored.

                                  7
<PAGE>

ITEM  2.   MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OF FINANCIAL CONDITION AND
           RESULTS  OF OPERATIONS,  CONTINUED:

Interest  and other income decreased from $6,193 during the first nine months of
2003  to $2,846 during the first nine months of 2004.  The decrease was due to a
corresponding  decrease  in  cash  bonds.

Financial  Condition  and  Liquidity

At  September  30,  2004,  Company  assets  totaled  $1,043,031, and there was a
stockholders'  deficit  of  $1,431,773.  The  stockholders'  deficit  decreased
$260,564 from December 31, 2003. The decrease is principally due to the issuance
of common stock in satisfaction of certain accrued legal fees and other payables
during  the  nine-month  period ended September 30, 2004. At September 30, 2004,
the  Company's  total  current  liabilities exceeded its total current assets by
$1,420,054.  Included  in  the  Company's  current  liabilities  are significant
delinquent  balances  due  to  raw  materials  suppliers, attorneys, and payroll
taxing  agencies.  The Company has, to date, been able to sustain its operations
through borrowings from major shareholders and sales of common stock. Due to the
Company's operating losses, negative working capital, and stockholders' deficit,
the Company's independent accountants included a paragraph in the Company's 2003
financial  statements  relating to a going concern uncertainty. To continue as a
going  concern  the  Company must generate profits from its antimony and zeolite
sales  and  acquire  additional  capital  resources  from  alternative financing
resources.  Without  financing and profitable operations, the Company may not be
able  to  meet its obligations, fund operations and continue in existence. While
management is optimistic that the Company will be able to sustain its operations
and  meet  its  financial  obligations,  there  can  be  no  assurance  of such.

     Cash  used by operating activities during the first nine months of 2004 was
$307,692  and  resulted  primarily  from  the  nine-month  net loss of $326,796.

Cash  used  by  investing  activities  during  the first nine months of 2004 was
$170,023  and  was almost entirely related to the construction of capital assets
at  the  Bear  River  Zeolite  facility.

Cash  provided by financing activities was $477,715 during the first nine months
of  2004,  and  was principally generated by proceeds from exercise of 2,136,070
warrants  for  $427,215  and  proceeds  from notes payable to banks of $174,419.

ITEM  3.     CONTROLS  AND  PROCEDURES

An  evaluation was performed under the supervision and with the participation of
our  management, including the President, of the effectiveness of the design and
operation  of  our disclosure controls and procedures. Based on that evaluation,
our  management, including the President, concluded that disclosure controls and
procedures  were  effective  as  of  September  30,  2004,  in ensuring that all
material information required to be filed in this quarterly report has been made
known  to  them  in  a  timely  fashion.

There has been no change in our internal control over financial reporting during
the  quarter  ended  September  30,  2004  that  has  materially affected, or is
reasonably  likely  to  materially  affect,  our internal control over financial
reporting.


                                           8


<PAGE>

                           PART II - OTHER INFORMATION

ITEM  1.     LEGAL  PROCEEDINGS

None

ITEM  2.     CHANGES  IN  SECURITIES

Neither  the  constituent  instruments  defining  the rights of the registrant's
securities  filers  nor  the  rights  evidenced  by the registrant's outstanding
common  stock  have been modified, limited or qualified.  During the three-month
period  ended  September  30,  2004,  the  Company  issued 200,000 shares of its
restricted  common stock in connection with the exercise of $0.20 stock purchase
warrants.  During  the  nine-month  period  ended September 30, 2004 the Company
issued  a total of 2,136,071 shares of its restricted common stock in connection
with  the  exercise  of  $0.20  stock purchase warrants. In addition, during the
nine-month period ended September 30, 2004, the Company issued 631,790 shares of
its  common  stock  in  connection  with  the extinguishment of certain accounts
payable  totaling  $150,145;  and  sold  66,667  shares  of its common stock for
$10,000  cash.


ITEM  3.     DEFAULTS  UPON  SENIOR  SECURITIES

The  registrant  has  no  outstanding  senior  securities.

ITEM  4.     SUBMISSION  OF  MATTERS  TO  A  VOTE  OF  SECURITY  HOLDERS

None

ITEM  5.     OTHER  INFORMATION

None

ITEM  6.     EXHIBITS  AND  REPORTS  ON  FORM  8-K

     Exhibits:  None


     Reports  on  Form  8-K:  None




                                      9



<PAGE>
                                    SIGNATURE


  Pursuant to the requirements of Section 13 or 15(b) of the Securities Exchange
    Act of 1934, the Registrant has duly caused this report to be signed on its
              behalf by the undersigned, thereunto duly authorized.


                       UNITED STATES ANTIMONY CORPORATION
                                  (Registrant)



          By:/s/John  C.  Lawerence     Date:  November  12,  2004
             ----------------------     --------------------------
                    John C. Lawrence, Director and President
             (Principal Executive, Financial and Accounting Officer)

                                  10

<PAGE>
                                  CERTIFICATION

I,  John  C.  Lawrence,  certify  that:

1.     I  have  reviewed  this  quarterly report on Form 10-QSB of United States
Antimony  Corporation

2.     Based  on my knowledge, this quarterly report does not contain any untrue
statement  of a material fact or omit to state a material fact necessary to make
the  statements  made, in light of the circumstances under which such statements
were  made,  not  misleading  with respect to the period covered by this report;

3.     Based  on  my  knowledge,  the  financial statements, and other financial
information included in this report, fairly present in all material respects the
financial  condition, results of operations and cash flows of the small business
issuer  as  of,  and  for,  the  periods  presented  in  this  report.

4.     I am responsible for establishing and maintaining disclosure controls and
procedures  (as  defined  in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
small  business  issuer  and  have:

a.     designed  such  disclosure  controls  and  procedures,  or  caused  such
disclosure  controls  and  procedures  to  be designed under our supervision, to
ensure  that  material  information  relating  to  the  small  business  issuer,
including  its  consolidated  subsidiaries, is made known to us by others within
those  entities,  particularly  during  the period in which this report is being
prepared;
b.     evaluated  the  effectiveness  of  the small business issuer's disclosure
controls  and procedures  and presented in this report our conclusions about the
effectiveness  of  the  disclosure controls and procedures, as of the end of the
period  covered  by  this  report  based  on  such  evaluation;  and
c.     Disclosed  in  this  report  any  change  in  the small business issuer's
internal  control  over  financial  reporting  that  occurred  during  the small
business  issuer's  most recent fiscal quarter  that has materially affected, or
is  reasonably likely to materially affect, the small business issuer's internal
control  over  financial  reporting;  and

5.     I  have disclosed, based on my most recent evaluation of internal control
over  financial reporting, to the small business issuer's auditors and the audit
committee  of  the  small  business  issuer's  board  of  directors  (or persons
performing  the  equivalent  functions);

a.     all  significant  deficiencies  and  material weaknesses in the design or
operation  of  internal  control  over  financial reporting which are reasonably
likely  to  adversely  affect  the  small  business  issuer's ability to record,
process,  summarize  and  report  financial  information;  and
b.     any  fraud,  whether  or  not material, that involves management or other
employees  who  have  a significant role in the small business issuer's internal
control  over  financial  reporting.


Date:  November  12,  2004
       -------------------


/s/John  C.  Lawrence
---------------------
John  C.  Lawrence
President,  Director  and  Principal  Financial  Officer



                          11
<PAGE>



CERTIFICATION  PURSUANT  TO  THE  SARBANES-OXLEY  ACT
18  U.S.C.  SECTION  1350
AS  ADOPTED  PURSUANT  TO  SECTION  906
OF  THE  SARBANES-OXLEY  ACT  OF  2002

I,  John  C.  Lawrence,  President,  Director and Principal Financial Officer of
United  States  Antimony  Corporation  ("the  "Registrant")  do  hereby certify,
pursuant  to  18  U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley  Act  of  2002,  that,  to  my  knowledge:

1.     This  Quarterly  Report  on  Form 10-QSB of the Registrant for the period
ended  September  30, 2004, as filed with the Securities and Exchange Commission
(the  "Report"),  fully complies with the requirements of Section 13(a) or 15(d)
of  the  Securities  Exchange  Act  of  1934;  and

2.     The  information contained in the Report fairly presents, in all material
respects,  the  financial condition and results of operations of the Registrant.
Date:  November  12,  2004
     ---------------------

/s/  John  C.  Lawrence
-----------------------
John  C.  Lawrence
President, Director  and  Principal  Financial  Officer


                                12
<PAGE>